Sensorineural hearing loss (SNHL) is a highly prevalent sensory disorder globally, affecting over 1.5 billion people, with a ...

The US Food and Drug Administration (FDA) has granted Fast Track Designation to Complement Therapeutics’ CTx001, the ...

Complement Therapeutics GmbH (CTx), a clinical-stage biotechnology company developing next-generation therapeutics for complement-mediated diseases, today announced that the U.S. Food and Drug ...

Analysts are intrested in these 5 stocks: ( ($VZLA) ), ( ($COTY) ), ( ($KLRS) ), ( ($ANNX) ) and ( ($BRO) ). Here is a breakdown of their recent ...

The classical pathway for complement activation is initiated by the formation of a complex between C1q and an antigen-antibody complex, setting off a cascade of proteolytic events that culminate in ...

Abstract: The construction of the new-type power system has a significant influence on the achievement of “Dual Carbon” goals in both the power system and the whole society. Currently, China is at a ...

A health system–wide lipid screening pathway significantly increased pediatric screening rates across a large primary care network. A structured, system-wide clinical pathway increased pediatric lipid ...

Meeting the needs of the community is one of North Idaho College President Nick Swayne’s main goals. So when he saw a growing trend toward classical education in the Inland Northwest with charter, ...

Novo Nordisk is paying $240 million for global rights to a Phase 3-ready drug from Omeros that could rival immune disorder medications currently available from companies such as AstraZeneca, Novartis, ...